Literature DB >> 24095975

Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy.

Richard J Saad1, William D Chey2.   

Abstract

The diagnosis of small intestinal bacterial overgrowth (SIBO) has increased considerably owing to a growing recognition of its association with common bowel symptoms including chronic diarrhea, bloating, abdominal distention, and the irritable bowel syndrome. Ideally, an accurate and objective diagnosis of SIBO should be established before initiating antibiotic treatment. Unfortunately, no perfect test exists for the diagnosis of SIBO. The current gold standard, small-bowel aspiration and quantitative culture, is limited by its high cost, invasive nature, lack of standardization, sampling error, and need for dedicated infrastructure. Although not without shortcomings, hydrogen breath testing provides the simplest noninvasive and widely available diagnostic modality for suspected SIBO. Carbohydrates such as lactulose and glucose are the most widely used substrates in hydrogen breath testing, with glucose arguably providing greater testing accuracy. Lactose, fructose, and sorbitol should not be used as substrates in the assessment of suspected SIBO. The measurement of methane in addition to hydrogen can increase the sensitivity of breath testing for SIBO. Diagnostic accuracy of hydrogen breath testing in SIBO can be maximized by careful patient selection for testing, proper test preparation, and standardization of test performance as well as test interpretation.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glucose Hydrogen Breath Test; Hydrogen Breath Test; Lactulose Hydrogen Breath Test; SIBO; Small Intestinal Bacterial Overgrowth

Mesh:

Substances:

Year:  2013        PMID: 24095975     DOI: 10.1016/j.cgh.2013.09.055

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  47 in total

1.  The Lactulose Breath Test in Irritable Bowel Syndrome: Is It All Hot Air?

Authors:  Rebecca E Burgell; Peter R Gibson
Journal:  Dig Dis Sci       Date:  2016-03       Impact factor: 3.199

2.  Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance.

Authors:  Mercedes Amieva-Balmori; Enrique Coss-Adame; Nikilesh S Rao; Brisa M Dávalos-Pantoja; Satish S C Rao
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

3.  Systematic review and meta-analysis: Small intestinal bacterial overgrowth in chronic pancreatitis.

Authors:  Gabriele Capurso; Marianna Signoretti; Livia Archibugi; Serena Stigliano; Gianfranco Delle Fave
Journal:  United European Gastroenterol J       Date:  2016-02-03       Impact factor: 4.623

4.  Following the Scent of Microbes Within: The Heart-Gut Connection.

Authors:  Chonyang Lu Albert; W H Wilson Tang
Journal:  J Card Fail       Date:  2019-03-26       Impact factor: 5.712

5.  The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.

Authors:  Manuele Furnari; Alessandra De Alessandri; Federico Cresta; Maria Haupt; Marta Bassi; Angela Calvi; Riccardo Haupt; Giorgia Bodini; Iftikhar Ahmed; Francesca Bagnasco; Edoardo Giovanni Giannini; Rosaria Casciaro
Journal:  J Gastroenterol       Date:  2018-09-19       Impact factor: 7.527

6.  Breath Testing for Small Intestinal Bacterial Overgrowth: A Means to Enrich Rifaximin Responders in IBS Patients?

Authors:  Amit Gupta; William D Chey
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

Review 7.  Diabetes and the Small Intestine.

Authors:  Jonathan Gotfried; Stephen Priest; Ron Schey
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

8.  Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth.

Authors:  Krishma Kumar; Mohammed Saadi; Frederick V Ramsey; Ron Schey; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2018-02-03       Impact factor: 3.199

9.  New and Emerging Treatment Options for Irritable Bowel Syndrome.

Authors:  Brian E Lacy; William D Chey; Anthony J Lembo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-04

Review 10.  Breath volatile organic compounds for the gut-fatty liver axis: promise, peril, and path forward.

Authors:  Steven Francis Solga
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.